Cardiovascular Risk in General Practice in France: Cardiovascular Risk Week

Completed

• Conditions: Healthy

• Registration Number: NCT01308372
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this study is to evaluate the proportion of patients which present a high cardiovascular risk estimated by the SCORE scale, in general practice consultations of the 7 French regions (Paris area, North-East, Paris basin, West, South-West, South- East, Mediterranean area)

Detailed Description

MC MD

Study Timeline

• Study First Submitted: 2011-02-18
• Study First Submitted QC: 2011-03-02
• Study First Posted: 2011-03-04
• Study Start: 2011-10
• Primary Completion: 2011-10
• Study Completion: 2011-10
• Status Verified: 2011-11
• Last Update Submitted: 2011-11-04
• Last Update Posted: 2011-11-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 9246

Inclusion Criteria

• Without any personal history of coronary disease
• Non treated with lipid-lowering agents
• Lipid test = 1 year old
• Presenting at least one cardiovascular risk
• Visiting their General Practitioner

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of cardiovascular risk in general practice in France estimated by the SCORE scale	1 week

Secondary Outcome Measures

Name	Time	Method
Evaluation of cardiovascular risk in general practice in France estimated by the Framingham 2008 scale D'Agostino	1 week
Evaluation of cardiovascular risk in general practice in France estimated by the Framingham 1998 scale Wilson	1 week
Evaluation of arteries age evaluation by SCORE	1 week

Trial Locations

Locations (1)

Research Site; 🇫🇷 Yutz, France